Latest on Pharmaceutical Industry


Australian Pharmaceutical Industries offers to buy Sigma Healthcare

Drug distributor Australian Pharmaceutical Industries (API) said on Friday it had offered about A$727 million ($524.9 million) to buy all of peer Sigma Healthcare Ltd, aiming to consolidate in the face of increased compe..Read More...

Generex Biotechnology Partner Olaregen Therapeutix Sponsors Annual Meeting of Innovations in Wound Healing

Generex Biotechnology Corporation announced today that Olaregen Therapeutix, a regenerative medicine company contracted to become a subsidiary of Generex, was a co-sponsor of the Annual Meeting of Innovations in Wound He..Read More...



9th ICBE—International Conference on Biomolecular Engineering

Newport Beach Marriott Hotel & Spa,


ICPSB 2019


Press Releases

FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia

Amgen today announced that the US Food and Drug Administration FDA has approved the supplemental Biologics License Application sBLA for Nplate romiplostim for the treatment of pediatric patients one year of age and older.. Read More...

New Therapeutic Area Leaders Extend PPD’s Drug Development Capabilities

Pharmaceutical Product Development LLC PPD is adding significant therapeutic expertise in cardiovascular disease critical care endocrinology metabolism and diabetes to further broaden its global product development portf.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer